Faustmann there is a lot going on in the world of cancer these days, and as you may know, much of it is focused on personalized medicine, that is treatments targeted based on the genetics of the cancer, which can vary from person to person. I’ve read recently, don’t recall where, that a class of drugs called PARP INHIBITORS, IS BEING LOOKED AT/USED, FOR PC. These drugs have been used successfully for Ovarian Cancer and are especially useful in patients who test positive for the BRCA gene.
So I’m guessing that’s where he’s going.
Dx Age 64 Nov 2014, PSA 4.3
BX 3 of 12 cores positive original pathologyG6, G6, G8 (3+5)
downgraded to 3+3=6 by Dr. Epstein, JH
RALP with Dr Ash Tewari Jan 6, 2015
Post surgical pathology – G7 (3+4), ECE, Margins, LN, SV all negative
PSA @ 6 weeks 2/15, .<02, remained <0.02 until January 2017, .02, repeat Feb 2017, still .02. May 2017-.033, August 2017- .033 November .046, March 2018 .060. June 2018 .068
Decipher test, low risk, .37 score
My story.... tinyurl.com/qgyu3xq